Variant report
Variant | nsv1009227 |
---|---|
Chromosome Location | chr3:144283031-144294326 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:62609055..62609630-chr3:144293870..144294370,2 | Hela-S3 | cervix: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000133316 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573447713 | chr3:144283046-144283047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs76339495 | chr3:144283058-144283059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138777683 | chr3:144283059-144283060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372550186 | chr3:144283092-144283093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs527796381 | chr3:144283095-144283096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548848727 | chr3:144283124-144283125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs77112428 | chr3:144283164-144283165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35871428 | chr3:144283184-144283185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73012753 | chr3:144283201-144283202 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs141460481 | chr3:144283205-144283206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568560295 | chr3:144283231-144283232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529368694 | chr3:144283287-144283288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73012756 | chr3:144283302-144283303 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs61641065 | chr3:144283333-144283334 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs539462185 | chr3:144283338-144283339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs377525788 | chr3:144283346-144283347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs191867895 | chr3:144283382-144283383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570041019 | chr3:144283387-144283388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147001029 | chr3:144283389-144283390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555580102 | chr3:144283435-144283436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573904693 | chr3:144283493-144283494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35122629 | chr3:144283504-144283505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546294426 | chr3:144283542-144283543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs138192275 | chr3:144283556-144283557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184068919 | chr3:144287800-144287801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6796913 | chr3:144287811-144287812 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs566474913 | chr3:144287823-144287824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148287889 | chr3:144288044-144288045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs78743597 | chr3:144288047-144288048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543058393 | chr3:144288065-144288066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs535146997 | chr3:144288072-144288073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs372116233 | chr3:144288105-144288106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547377852 | chr3:144288124-144288125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs141475266 | chr3:144288140-144288141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs534117867 | chr3:144288141-144288142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs112114243 | chr3:144288166-144288167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187742431 | chr3:144288226-144288227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552688648 | chr3:144288242-144288243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs80324727 | chr3:144288252-144288253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs192259913 | chr3:144288280-144288281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs9817588 | chr3:144288302-144288303 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs146323563 | chr3:144288394-144288395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538196150 | chr3:144288411-144288412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs76145060 | chr3:144288463-144288464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572587645 | chr3:144288464-144288465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs546018645 | chr3:144288500-144288501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9856190 | chr3:144288547-144288548 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs575769730 | chr3:144288573-144288574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543121863 | chr3:144288591-144288592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs143001481 | chr3:144288596-144288597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 21129771 | CNVD |
Ovarian cancer | 23621864 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 21509527 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:144282600-144283600 | Enhancers | HUVEC | blood vessel |
2 | chr3:144282800-144283400 | Enhancers | Muscle Satellite Cultured Cells | -- |
3 | chr3:144282800-144283400 | Enhancers | Skeletal Muscle Male | skeletal muscle |
4 | chr3:144287800-144289400 | Enhancers | Fetal Lung | lung |
5 | chr3:144288800-144289600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |